Germany blocks deregulation of NGT breeds
The Spanish EU Council Presidency wanted to speed up a decision on the new regulation that foresees to allow a faster market approval of breeds made...
EU parliament backs deregulation of New Genome Techniques
With the MEPs' approval of the amendments to the European Commission's draft legislation, the way is now clear for a regulation that distinguishes...
Cathera SA closes Series B round at €42m
The Series B update was led by Unorthodox Ventures. Existing shareholders Supernova Invest, Saint-Genys and Bouscas Med also participated in the...
Pierre Fabre SAS in US$31m licence deal with Kinnate Biopharma Inc
With the US$31m agreement Pierre Fabre licences the global rights to exarafenib and other pan-RAF program assets from Kinnate...
Researcher find potential target for atherosclerosis
Researchers have found a new way to reverse atherosclerotic plaque formation at the early stages. In Nature Cardiovascular Research, Alma...
Vandria SA bags CHF18m in Series A financing
agSwiss Vandria SA said it will use the proceeds from a CHF18m Series A financing led by ND Capital and a syndicate of HNW private investors to...
Metrion Biosciences closes £3.7m equity financing
The company announced that the funding will be used to expand Metrion’s new (2021) laboratories in Cambridge, UK, invest in specialist...